Anemia  >>  Monofer (iron isomaltoside 1000)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Monofer (iron isomaltoside 1000) / Pharmacosmos
PK-CIA-04, NCT01213979: Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (MonoferĀ®) Administered by 500 mg IV Bolus Injection or 1000 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy Induced Anaemia (CIA)

Completed
1
16
RoW
500 mg iron isomaltoside 1000, 1000 mg iron isomaltoside 1000
Pharmacosmos A/S
Non-hematological Malignancies
05/12
07/12
PK-CIA-06, NCT01280240: Pharmacokinetic Study of Iron Isomaltoside 1000 Administered by 250 mg IV Bolus Injection or 500 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy Induced Anaemia

Completed
1
11
US
Monofer(R), iron isomaltoside 1000
Pharmacosmos A/S
Patients With Chemotherapy Induced Anemia (CIA)
09/12
11/12
NCT03013439: Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (MonoferĀ®)

Completed
1
24
Japan
Iron Isomaltoside, Monofer
Pharmacosmos A/S
Anemia, Deficiency Diseases, Anemia, Iron Deficiency, Hematologic Disease, Iron Metabolism Disorders
06/17
06/17

Download Options